On May 9, Ge Longhui (603739.SH) announced serious abnormal fluctuations in stock trading. The cumulative deviation value of the company's stock closing price increase exceeded 100% within 10 consecutive trading days (April 25, 2024 to May 9, 2024). According to the relevant provisions of the “Shanghai Stock Exchange Trading Rules”, this is a serious abnormal fluctuation in stock trading.
Recently, the company noticed reports on “synthetic biology” published on the Internet and some media. The company has set up only 1 synthetic biotechnology innovation laboratory in the field of synthetic biology, which is mainly used to develop functional proteins for feed, sweeteners for food, etc. However, the laboratory has few R&D projects in reserve, small investment amounts, and few professionals. Currently, it is still in the early stages of bacterial laboratory research and development. There is still a big gap between large-scale expansion, and it does not have the conditions for industrialization. The production of synthetic biology products involves production processes such as separation and purification, and the purification process is very difficult. Currently, the company does not have this process and needs to be further developed. At the same time, the future of products may also involve registration and regulatory approval, product selection and marketing, etc. The cycle is long and difficult, and there is significant uncertainty about commercialization. It is expected that it will not have a significant impact on the company's operations over a long period of time. Other than that, the company does not invest in R&D in other fields of synthetic biology.